Aimed Bio Inc. (KOSDAQ: A0009K0)
Health Care · Biotechnology · KR
₩24,250.00
-2.22% today · -44.9% 1Y
Aimed Bio Inc. (KOSDAQ: A0009K0) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.17B.
Over the last twelve months the share price has lost 44.9%, trading between 17.40K and 80.20K.
Tweenvest scores Aimed Bio Inc. across four factors: quality 70/100, value 14/100. Its strongest factor is quality.
A0009K0 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.17B
- Revenue (TTM)
- $43.13M
- P/E
- 41.19
- EPS
- 588.67
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- ₩80,200.00
- 52-week low
- ₩17,400.00
- Avg volume (3M)
- —
- Shares outstanding
- 64.67M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| BioGaia AB (publ)OM: BIOG B | $1.18B | Skr116.80 | +1.21% |
| Vor Biopharma Inc.NasdaqGS: VOR | $1.18B | $19.89 | -0.05% |
| NatureCell Co.,Ltd.KOSDAQ: A007390 | $1.18B | ₩24,550.00 | -0.81% |
| HBM Holdings LimitedSEHK: 2142 | $1.17B | HK$11.14 | -17.11% |
| Bicara Therapeutics Inc.NasdaqGM: BCAX | $1.16B | $17.25 | -1.43% |
| Amoy Diagnostics Co., Ltd.SZSE: 300685 | $1.16B | CN¥20.30 | -4.87% |
| Nanjing Leads Biolabs Co., Ltd.SEHK: 9887 | $1.13B | HK$45.56 | -9.69% |
| L&C BIO Co.,LTDKOSDAQ: A290650 | $1.13B | ₩56,400.00 | +5.03% |
Figures last refreshed Oct 11, 2026.